美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾格里房產

74.50

-0.4300-0.57%

盤前：73.67-0.8300-1.11%09:05 EDT

成交量：108.62萬

成交額：8,086.03萬

市值：81.81億

市盈率：42.12

高：74.91

開：74.82

低：73.88

收：74.93

資料載入中...

總覽公司新聞公告

當乳腺癌診療邂逅AI，中國能否率先叩開精準智能均質時代大門？

ADC明星企業映恩生物登陸港交所，盤中漲幅高達116.7%

暴漲130%！映恩生物正式登陸港交所，市值超181億港元，抗體偶聯藥物ADC領域全球領跑者

【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿，映恩生物(09606.HK)漲91.33%。消息方面，該公司在昨日的暗盤大漲87.1%。根據公開資料，映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業，致力於為癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。

新股首日 | 映恩生物-B(09606)首掛上市早盤高開91.33% 公司為ADC創新藥物研發商

藥明生物斬獲五項亞太生物工藝卓越獎

火爆！18A最大IPO誕生！映恩生物創ADC港股神話

FDA計劃逐步讓“猴哥”退出新藥研發？提出三大替代方向，但業內認為還需更多研究

每日经济新闻

映恩生物(09606)港股IPO創18A生物科技多項紀錄全球資本熱捧ADC賽道領軍者

智通财经网

醫保藥品丙類目錄進度不及預期商保目錄徵求意見啓動

港股異動 | 藥明合聯(02268)反彈逾14% 大摩指公司有望受惠全球強勁的外包需求及全球現有ADC產能稀缺性

映恩生物今起招股：獲十餘家機構超5億港元基石認購，擁有12條ADC管線

中國生物製藥：“TQB6411 (EGFR/c-Met雙抗ADC)”臨牀試驗申請獲CDE受理

中國生物製藥(01177)研發的抗腫瘤藥“TQB2101 (ROR1 ADC)”獲得NMPA的臨牀試驗默示許可

何如意離職後，“ADC第一股”榮昌生物的醫學副總裁也跳槽了，去年虧損收窄至14.68億

【凱萊英：2024年淨利潤同比下降58.17% 擬10派11元】凱萊英公告，公司2024年實現營業收入58.05億元，同比下降25.82%；淨利潤9.49億元，同比下降58.17%；基本每股收益2.69元。公司擬每10股派發現金紅利11元（含稅）。報告期內，公司小分子業務已經基本消化了大訂單退潮帶來的資源冗餘，盈利水平已經恢復到歷史上較好水平。公司化學大分子業務在多肽、核酸、ADC等領域展現出積極態勢，四季度收入佔全年收入比例超過45%。

禮來Nectin-4靶向ADC癌症新藥在中國獲批臨牀

中信建投：持續看好創新藥行業

【大行評級｜里昂：上調科倫博泰生物-B目標價至328.4港元重申“跑贏大市”評級】里昂發表研究報告指，科倫博泰生物-B去年收入按年升25.5%至19.33億元，淨虧損按年收窄53.5%至2.67億元，均勝於預期。公司初步建立其銷售團隊，目標維持今年蘆康沙妥珠單抗(sac-TMT)藥物銷售達8億至10億元。該行指，進一步標籤擴充(label expansion)蘆康沙妥珠單抗及靶向人類表皮生長因子受體2(HER2)的抗體藥物偶聯物(ADC)獲批准等均是今年值得關注的重點。該行指，將公司今年及明年銷售預測分別下調4.5%及5%，其純利預測分別下調27.4%及24.1%。該行將其目標價由236.6港元上調至328.4港元，重申其評級為“跑贏大市”。

信達生物將在美國癌症研究協會（AACR）2025年會公佈多項臨牀前數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADC/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":74.5,"timestamp":1747944000000,"preClose":74.93,"halted":0,"volume":1086157,"hourTrading":{"tag":"盘前","latestPrice":73.67,"preClose":74.5,"latestTime":"09:05 EDT","volume":34,"amount":2532.94458,"timestamp":1748005512912},"delay":0,"floatShares":107727624,"shares":109806548,"eps":1.768583,"marketStatus":"盤前交易","change":-0.43,"latestTime":"05-23 09:05:17 EDT","open":74.82,"high":74.91,"low":73.875,"amount":80860332.939762,"amplitude":0.013813,"askPrice":75.34,"askSize":1,"bidPrice":71.69,"bidSize":3,"shortable":3,"etf":0,"ttmEps":1.768583,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748007000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.5,"dividendRate":0.04051,"preHourTrading":{"tag":"盘前","latestPrice":73.67,"preClose":74.5,"latestTime":"09:05 EDT","volume":34,"amount":2532.94458,"timestamp":1748005512912},"postHourTrading":{"tag":"盘后","latestPrice":74.5,"preClose":74.5,"latestTime":"17:51 EDT","volume":18559,"amount":1382642.91,"timestamp":1747950711510},"volumeRatio":1.0747974656287616,"impliedVol":0.2196,"impliedVolPercentile":0.5703},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":107727624,"roa":"2.30%","roe":"3.55%","lyrEps":1.793039,"volumeRatio":1.0747974656287616,"shares":109806548,"dividePrice":3.018,"high":74.91,"amplitude":0.013813,"preClose":74.93,"low":73.875,"week52Low":58.52,"pbRate":"1.50","psRate":"12.85","week52High":79.65,"institutionHeld":0.8991,"latestPrice":74.5,"committee":0.5,"eps":1.768583,"divideRate":0.04051,"volume":1086157,"delay":0,"ttmEps":1.768583,"open":74.82,"prevYearClose":70.45,"prevWeekClose":74.92,"prevMonthClose":77.61,"prevQuarterClose":77.19,"fiveDayClose":73.92,"twentyDayClose":76.29,"sixtyDayClose":72.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527102958","title":"當乳腺癌診療邂逅AI，中國能否率先叩開精準智能均質時代大門？","url":"https://stock-news.laohu8.com/highlight/detail?id=2527102958","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527102958?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:47","pubTimestamp":1744685233,"startTime":"0","endTime":"0","summary":"“乳腺癌诊疗正迈向精准化、智能化的新阶段，此次发布的三大成果将为中国乳腺癌规范化诊疗注入强劲动力，引领诊疗新时代。”此次大会，正式发布了《CSCO乳腺癌诊疗指南2025》《中国乳腺癌诊疗指南2025》及全新升级的CSCO AI Pro人工智能辅助决策系统三大核心成果。作为大会的重头戏之一，《CSCO乳腺癌诊疗指南2025》于4月11日下午正式发布，并同步启动了全国巡讲计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4MHfAOpL0ed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["LU1059921491.USD","BK4588","BK4515","CSCO","ADC","LU0868494708.USD","LU1894683348.USD","BK4525","BK4550","LU1066053197.SGD","SG9999015986.USD","BK4585","IE00BGHQF631.EUR","IE00B42XCP33.USD","SG9999002232.USD","LU1066051498.USD","LU1571399168.USD","LU0203347892.USD","LU2247934214.USD","LU0950375773.USD","IE00BZ1G4Q59.USD","LU0348723411.USD","LU1235294995.USD","LU2237443465.HKD","LU1894683264.USD","LU2506952097.USD","LU0731783394.SGD","LU1066051225.USD","BK4020","LU2506951958.HKD","BK4527","LU0889566641.SGD","IE00BDGV0183.EUR","LU0942090050.USD","LU2237443978.SGD","SG9999001424.SGD","IE00BVYPNV92.GBP","LU0792757196.USD","IE00B3PB1722.GBP","BK4560","IE00B3T34201.USD","LU1585245621.USD","LU2506951875.HKD","LU1823568750.SGD","LU0823417737.USD","LU1430594728.SGD","IE00BVYPNW00.USD","LU1880398471.USD","LU2506952170.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2527410652","title":"ADC明星企業映恩生物登陸港交所，盤中漲幅高達116.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527410652","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527410652?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:10","pubTimestamp":1744683017,"startTime":"0","endTime":"0","summary":"4月15日，ADC明星企业映恩生物-B（09606.HK）正式登陆港交所。截至发稿，映恩生物报205港元/股，涨幅116.7%。映恩生物IPO发行定价为94.6港元/股，认购情况火爆，募资总额约2.1亿美元（约合人民币15.4亿元），这是自2022年来募资规模最大的港股18A企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504153377128371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09606","ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2527102312","title":"暴漲130%！映恩生物正式登陸港交所，市值超181億港元，抗體偶聯藥物ADC領域全球領跑者","url":"https://stock-news.laohu8.com/highlight/detail?id=2527102312","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527102312?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:52","pubTimestamp":1744681920,"startTime":"0","endTime":"0","summary":"　　映恩生物-B今日成功在港交所主板上市，Morgan Stanley、Jefferies以及CITIC Securities为联席保荐人。　　映恩生物是全球抗体偶联药物领域的关键领跑者，致力于为癌症和自身免疫性疾病等患者研发ADC创新药物。　　公司拥有自主研发的两款核心产品，即DB-1303/BNT323及DB-1311/BNT324。　　今日开盘，映恩生物涨130.44%，报218.00港元/股，市值181.32亿港元。　　截至2月19日，公司尚未获得任何候选药物的上市批准，亦未从产品销售中获得任何收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-15/doc-inetfhrt7419875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4080","ADC","BK4231","09606"],"gpt_icon":1},{"id":"2527628177","title":"【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿，映恩生物(09606.HK)漲91.33%。消息方面，該公司在昨日的暗盤大漲87.1%。根據公開資料，映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業，致力於為癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527628177","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527628177?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:27","pubTimestamp":1744680474,"startTime":"0","endTime":"0","summary":"截至发稿，映恩生物(09606.HK)涨91.33%。消息方面，该公司在昨日的暗盘大涨87.1%。根据公开资料，映恩生物是一家专注于新一代抗体偶联药物研发的创新生物制药企业，致力于为癌症和自身免疫性疾病等患者研发新一代ADC创新药物。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15092749540314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","09606","06978","ADC","BK1574","159992","BK4231","BK4080"],"gpt_icon":0},{"id":"2527177835","title":"新股首日 | 映恩生物-B(09606)首掛上市 早盤高開91.33% 公司為ADC創新藥物研發商","url":"https://stock-news.laohu8.com/highlight/detail?id=2527177835","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527177835?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:21","pubTimestamp":1744680097,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B首挂上市，公告显示，每股定价94.6港元，共发行1733.23万股股份，每手100股，所得款项净额约15.13亿港元。截至发稿，涨91.33%，报181港元，成交额7.82亿港元。公开资料显示，映恩生物于2020年正式运营，是抗体偶联药物领域的全球领跑者。其中多项临床阶段的ADC，在17个国家230多个临床试验中心开展7项全球临床试验，已入组超过2000多名患者，50%患者来自海外。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","ADC","BK1161","159992","BK1574","BK4231","06978","BK4080"],"gpt_icon":1},{"id":"2527019458","title":"藥明生物斬獲五項亞太生物工藝卓越獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2527019458","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527019458?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 21:08","pubTimestamp":1744636080,"startTime":"0","endTime":"0","summary":"药明生物首席执行官陈智胜博士表示：\"此次药明生物斩获的多项荣誉有力地证明了我们为全球客户和生物制药行业提供的价值。药明生物在中国、美国、爱尔兰、德国和新加坡拥有超过12000名员工。截至2024年12月底，药明生物帮助客户研发和生产的综合项目高达817个，其中包括21个商业化生产项目。药明生物以可持续发展为长期业务增长的基石。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4663759_ZH63759_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4550","LU0823426308.USD","LU0039217434.USD","IE00B19Z3581.USD","BK4588","LU2237438978.USD","BK4121","LU0051755006.USD","LU1242518857.USD","BK1576","LU0417516902.SGD","LU1242518931.SGD","02269","BK4088","BK4585","IE0004091025.USD","BK4231","LU0516422366.SGD","LU0251142724.SGD","LU0061475181.USD","LU0516422440.USD","LU0742534661.SGD","LU1668664300.SGD","LU1688375341.USD","LU0140636845.USD","LU0708995583.HKD","BK1141","LU0307460666.USD","BK4533","LU0456846285.SGD","CCS","PFS","LU0320764599.SGD","IE00B19Z3B42.SGD","LU0326950275.SGD","LU2237443895.HKD","BK4195","ADC","IE0004086264.USD","WXXWY","BK4080","BK4504","BK1521","LU0516422952.EUR","LU0052750758.USD","LU0979878070.USD","LU0181495838.USD","LU0588546209.SGD","IE00B0JY6N72.USD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2527984976","title":"火爆！18A最大IPO誕生！映恩生物創ADC港股神話","url":"https://stock-news.laohu8.com/highlight/detail?id=2527984976","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527984976?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 12:21","pubTimestamp":1744604460,"startTime":"0","endTime":"0","summary":"创近4年最大18A上市案例。同时，2025年医疗板块估值修复，港股18A企业平均股价涨幅翻倍，资本对ADC赛道的押注从谨慎转向狂热。ADC赛道进入价值重估阶段尽管IPO表现亮眼，映恩生物仍面临商业化与资金链考验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-14/doc-inetccsy8932121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["YANG","BK4080","09606","HSTECH","BK4614","BK4231","ADC"],"gpt_icon":1},{"id":"2526692983","title":"FDA計劃逐步讓“猴哥”退出新藥研發？ 提出三大替代方向，但業內認為還需更多研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2526692983","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526692983?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 22:44","pubTimestamp":1744469040,"startTime":"0","endTime":"0","summary":"美国时间4月10日，美国食品药品监督管理局（FDA）官网更新了一则具有里程碑意义的政策调整：计划逐步取消在单克隆抗体疗法和其他药物研发中对动物实验的强制性要求。实际上，2022年FDA就通过了《FDA现代化法案2.0》，提倡寻找动物实验的替代方案，但最新政策更加具体，指明了智能计算模型、类器官与器官芯片、跨物种数据整合的三大替代方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504123375140467.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504123375140467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2526672268","title":"映恩生物(09606)港股IPO創18A生物科技多項紀錄 全球資本熱捧ADC賽道領軍者","url":"https://stock-news.laohu8.com/highlight/detail?id=2526672268","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526672268?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 14:32","pubTimestamp":1744439520,"startTime":"0","endTime":"0","summary":"市场消息称，映恩生物此次IPO创下18A生物科技公司多项历史纪录：1、估值跃升三倍，公司成为港股18A板块中估值增幅最大的项目。映恩生物于2020年正式运营，是抗体偶联药物领域的全球领跑者。其中多项临床阶段的ADC，在17个国家230多个临床试验中心开展7项全球临床试验，已入组超过2000多名患者，50%患者来自海外。财务方面，得益于ADC出海，映恩生物营收增长态势无虞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-12/doc-ineswvux1593953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","HSTECH","09606","BK4080","BK4614","YANG","ADC","159837"],"gpt_icon":1},{"id":"2526305562","title":"醫保藥品丙類目錄進度不及預期 商保目錄徵求意見啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2526305562","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526305562?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 12:42","pubTimestamp":1744260166,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["ADC","BK1161","LU1169590202.USD","06978","BK1574","BK4023","CAR","PD","159992","BK4022","BK4231","BK4080","LU1169589451.USD","BK4230"],"gpt_icon":0},{"id":"2526737868","title":"港股異動 | 藥明合聯(02268)反彈逾14% 大摩指公司有望受惠全球強勁的外包需求及全球現有ADC產能稀缺性","url":"https://stock-news.laohu8.com/highlight/detail?id=2526737868","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526737868?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 09:45","pubTimestamp":1744249542,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明合联(02268)反弹逾14%，截至发稿，涨14.53%，报33.45港元，成交额1.99亿港元。大摩发布研报指出，根据去年订单积压趋势及今年业绩指引，确认药明系3间公司前景改善，推动了3月份股价上涨。全球生物技术融资正常化、中国药物海外授权、海外设施资本支出及商业项目增加，是推动增长主要驱动力。大摩表示，药明合联仍是该行首选，相信公司在2024至2030年期间持续高于行业增长，受惠全球强劲的外包需求及全球现有ADC产能稀缺性。中国对全球药物授权增加对公司未来收入增长有利，因公司去年中国授权交易规模超过10亿美元的ADC中占据约六成分额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1276520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1074936037.SGD","BK4516","LU0912757837.SGD","LU0795875169.SGD","LU0225283273.USD","LU1720051017.SGD","LU2271345857.HKD","LU2111349929.HKD","LU0006306889.USD","BK4231","BK4534","LU2028103732.USD","BK4585","LU0098860793.USD","BK4504","LU2133065610.SGD","LU0158827781.USD","LU1989772840.SGD","LU2357305700.SGD","SG9999014674.SGD","BK4581","BK4588","LU0795875086.SGD","LU1668664300.SGD","LU0158827948.USD","LU1989772923.USD","LU1732800096.USD","BK4127","LU1720051108.HKD","LU1732799900.SGD","LU0267386448.USD","LU0106831901.USD","BK4080","02268","LU0971096721.USD","LU1162221912.USD","LU1548497426.USD","LU2089284900.SGD","LU2488822045.USD","ADC","LU0314104364.USD","LU1363072403.SGD","LU2089283258.USD","LU0320765646.SGD","BK1141","LU2347655156.SGD","IE00BZ1G4Q59.USD","LU2023251221.USD","IE00BKVL7J92.USD","LU0106261372.USD"],"gpt_icon":0},{"id":"2525375640","title":"映恩生物今起招股：獲十餘家機構超5億港元基石認購，擁有12條ADC管線","url":"https://stock-news.laohu8.com/highlight/detail?id=2525375640","media":"IPO早知道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525375640?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 10:29","pubTimestamp":1743992940,"startTime":"0","endTime":"0","summary":"　　已签订超60亿美元合作交易。　　据IPO早知道消息，Duality Biotherapeutics， Inc．今日开启招股、至10日结束，并计划于2025年4月15日正式以“9606”为股票代码在港交所主板挂牌上市。　　映恩生物计划在本次IPO中发行15，071，600股股份。　　成立于2019年的映恩生物致力于为癌症和自身免疫性疾病等患者研发ADC创新药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-04-07/doc-ineshzpw1601241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2524264572","title":"中國生物製藥：“TQB6411 (EGFR/c-Met雙抗ADC)”臨牀試驗申請獲CDE受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2524264572","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524264572?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 22:58","pubTimestamp":1743692288,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，本集团自主研发的“TQB6411 ”已向中国国家药品监督管理局药品评审中心提交临床试验申请，并获得受理。TQB6411是一种靶向EGFR、c-Met的抗体偶联药物，静脉注入血后抗体部分与肿瘤细胞表面 EGFR、c-Met结合阻断EGFR、c-Met信号通路，ADC经细胞内吞并转运到溶酶体，连接子经酶切后释放出DDDXD，导致DNA损伤和细胞死亡。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","ADC","BK1589","BK1191","BK1521","BK1576","BK1583","BK4017","BK1141","01177","BK1515","BK4231","CDE","03347"],"gpt_icon":0},{"id":"2524261031","title":"中國生物製藥(01177)研發的抗腫瘤藥“TQB2101 (ROR1 ADC)”獲得NMPA的臨牀試驗默示許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2524261031","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524261031?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 22:53","pubTimestamp":1743692000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)公布，该集团自主研发的“TQB2101 (ROR1 ADC)”已获得中国国家药品监督管理局(NMPA)的临床试验默示许可，拟用于治疗晚期恶性肿瘤。临床前研究数据显示，TQB2101在多种ROR1阳性肿瘤模型中展现出抗肿瘤活性，且具有良好的安全性特征。此次获批的I期临床试验将重点评估其在人体内的安全性、耐受性、药代动力学特性及初步疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1141","ADC","03347","01177","BK1521","BK1191","BK1583","BK4231","BK1589","BK4080","BK1576"],"gpt_icon":0},{"id":"2524230716","title":"何如意離職後，“ADC第一股”榮昌生物的醫學副總裁也跳槽了，去年虧損收窄至14.68億","url":"https://stock-news.laohu8.com/highlight/detail?id=2524230716","media":"时代财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524230716?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 19:05","pubTimestamp":1743678358,"startTime":"0","endTime":"0","summary":"4月2日，先通医药官宣一则人事任命。根据先通医药微信公众号，王岩博士正式加入公司，担任首席医学官（CMO）及临床开发高级副总裁。王岩将与公司的管理团队紧密合作，共同推动临床业务的发展，助力公司迈向新的高度。王岩曾任解放军总医院第五医学中心副主任医师及科室副主任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504033364973781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1574","LU2328871848.SGD","LU1969619763.USD","ADC","BK4080","09995","BK1161","BK4231"],"gpt_icon":0},{"id":"2522733565","title":"【凱萊英：2024年淨利潤同比下降58.17% 擬10派11元】凱萊英公告，公司2024年實現營業收入58.05億元，同比下降25.82%；淨利潤9.49億元，同比下降58.17%；基本每股收益2.69元。公司擬每10股派發現金紅利11元（含稅）。報告期內，公司小分子業務已經基本消化了大訂單退潮帶來的資源冗餘，盈利水平已經恢復到歷史上較好水平。公司化學大分子業務在多肽、核酸、ADC等領域展現出積極態勢，四季度收入佔全年收入比例超過45%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2522733565","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522733565?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 19:55","pubTimestamp":1743162904,"startTime":"0","endTime":"0","summary":"凯莱英公告，公司2024年实现营业收入58.05亿元，同比下降25.82%；净利润9.49亿元，同比下降58.17%；基本每股收益2.69元。公司拟每10股派发现金红利11元（含税）。报告期内，公司小分子业务已经基本消化了大订单退潮带来的资源冗余，盈利水平已经恢复到历史上较好水平。公司化学大分子业务在多肽、核酸、ADC等领域展现出积极态势，四季度收入占全年收入比例超过45%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/28195549133125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06821","ADC","002821"],"gpt_icon":0},{"id":"2522634145","title":"禮來Nectin-4靶向ADC癌症新藥在中國獲批臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2522634145","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522634145?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 09:16","pubTimestamp":1743124577,"startTime":"0","endTime":"0","summary":"公开资料显示，这是一款在研的抗Nectin-4抗体偶联药物，正在国际范围内开展1期临床研究。本次是该产品首次在中国获批IND。正常组织仅表达低至中等水平的Nectin-4，这使得该蛋白成为癌症治疗的一个有吸引力的靶点。该产品还在多种Nectin-4表达和MMNE耐药的肿瘤模型中显示出强大的体内疗效。总体来看，LY4052031作为下一代疗法治疗Nectin-4阳性肿瘤具有特异性、选择性、效力和有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032809231594c373c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032809231594c373c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2360106947.USD","IE00B1BXHZ80.USD","BK4080","SGXZ31699556.SGD","BK4516","LU0106261372.USD","LU2106854487.HKD","LU0198837287.USD","LU1280957306.USD","LU0256863811.USD","LU0354030511.USD","LU1720051108.HKD","LU0114720955.EUR","LU2361045086.USD","LU0466842654.USD","LU1291159041.SGD","LU1868836914.USD","ADC","LU0672654240.SGD","BK4588","LU1548497426.USD","LU1868836591.USD","LU0823416689.USD","LU1623119135.USD","SG9999015952.SGD","LU2468319806.SGD","LU1983299246.USD","SG9999018857.SGD","SG9999014898.SGD","LU0882574139.USD","SGXZ99366536.SGD","LU2237443622.USD","LU2265009873.SGD","BK4534","LU1061106388.HKD","LU2237443382.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","IE00BK4W5M84.HKD","LLY","LU1551013425.SGD","LU2361044949.HKD","IE00BJJMRZ35.SGD","SG9999015978.USD","LU2237443465.HKD","LU0820561818.USD","LU1814569148.SGD","LU0238689110.USD","LU0385154629.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2522796554","title":"中信建投：持續看好創新藥行業","url":"https://stock-news.laohu8.com/highlight/detail?id=2522796554","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522796554?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 08:04","pubTimestamp":1743120280,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["601066","BK4144","BK4080","GLP","BK4590","BK0276","06978","BK1161","BK1574","BK4231","ADC","159992"],"gpt_icon":0},{"id":"2522439111","title":"【大行評級｜里昂：上調科倫博泰生物-B目標價至328.4港元 重申“跑贏大市”評級】里昂發表研究報告指，科倫博泰生物-B去年收入按年升25.5%至19.33億元，淨虧損按年收窄53.5%至2.67億元，均勝於預期。公司初步建立其銷售團隊，目標維持今年蘆康沙妥珠單抗(sac-TMT)藥物銷售達8億至10億元。該行指，進一步標籤擴充(label expansion)蘆康沙妥珠單抗及靶向人類表皮生長因子受體2(HER2)的抗體藥物偶聯物(ADC)獲批准等均是今年值得關注的重點。該行指，將公司今年及明年銷售預測分別下調4.5%及5%，其純利預測分別下調27.4%及24.1%。該行將其目標價由236.6港元上調至328.4港元，重申其評級為“跑贏大市”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2522439111","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522439111?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 11:11","pubTimestamp":1743045118,"startTime":"0","endTime":"0","summary":"里昂发表研究报告指，科伦博泰生物-B去年收入按年升25.5%至19.33亿元，净亏损按年收窄53.5%至2.67亿元，均胜于预期。公司初步建立其销售团队，目标维持今年芦康沙妥珠单抗(sac-TMT)药物销售达8亿至10亿元。该行指，进一步标签扩充(label expansion)芦康沙妥珠单抗及靶向人类表皮生长因子受体2(HER2)的抗体药物偶联物(ADC)获批准等均是今年值得关注的重点。该行指，将公司今年及明年销售预测分别下调4.5%及5%，其纯利预测分别下调27.4%及24.1%。该行将其目标价由236.6港元上调至328.4港元，重申其评级为“跑赢大市”。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/27111149078884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADC","06990"],"gpt_icon":0},{"id":"2522296398","title":"信達生物將在美國癌症研究協會（AACR）2025年會公佈多項臨牀前數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2522296398","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522296398?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 09:17","pubTimestamp":1743038220,"startTime":"0","endTime":"0","summary":"美国旧金山和中国苏州2025年3月27日 /美通社/ -- 信达生物制药集团，一家致力于研发、生产和销售肿瘤、自身免疫、代谢及心血管、眼科等重大疾病领域创新药物的生物制药公司，今日宣布，将在 2025 年美国癌症研究协会年会上公布多项最新临床前数据，包括公司旗下一系列双抗、多抗及抗体偶联药物肿瘤管线。截至目前，信达生物患者援助项目已惠及20余万普通患者，药物捐赠总价值36亿元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4651166_ZH51166_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1583","BK4139","BK4213","LU0266512127.USD","LU1969619763.USD","CRC","BK1589","BK1161","01801","LU2488822045.USD","LU0456854461.SGD","LU2328871848.SGD","IVBIY","BK4231","BK4080","ADC"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"date":"2025-04-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"},{"market":"US","date":"2025-04-22","symbol":"ADC","fiscalQuarterEnding":"2025/03","expectedEps":1.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1745294400000,"reportTimeType":"post","actualEps":1.06},{"date":"2025-03-31","symbol":"ADC","amount":0.253,"announcedDate":"2025-03-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-14"},{"date":"2025-02-28","symbol":"ADC","amount":0.253,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-14","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-14","value":0.465,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-13","value":0.465,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":21,"updateTime":1746676800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-05-22","current":43.002313,"percent":0.679414,"low":31.539495,"twenty":37.571542,"median":40.653059,"eighty":44.677947,"high":53.261716,"avg":41.113443,"sd":4.473729,"marketCap":8227804641},"quantilePoints":[{"date":"2020-05-29","current":40.87144,"twenty":30.127131,"median":35.446997,"eighty":42.650816,"marketCap":3390817259},{"date":"2020-06-05","current":44.67404,"twenty":30.209273,"median":35.585113,"eighty":42.788104,"marketCap":3706292371},{"date":"2020-06-12","current":43.306667,"twenty":30.259415,"median":35.631973,"eighty":42.882133,"marketCap":3592850978},{"date":"2020-06-19","current":43.938263,"twenty":30.399208,"median":35.674606,"eighty":42.926676,"marketCap":3645250098},{"date":"2020-06-26","current":40.969109,"twenty":30.470777,"median":35.744304,"eighty":42.989446,"marketCap":3398920216},{"date":"2020-07-02","current":43.619209,"twenty":30.497525,"median":35.833506,"eighty":43.024146,"marketCap":3618780439},{"date":"2020-07-10","current":41.587683,"twenty":30.543737,"median":35.93098,"eighty":43.037844,"marketCap":3450238941},{"date":"2020-07-17","current":42.77274,"twenty":30.603622,"median":36.099734,"eighty":43.037844,"marketCap":3548554815},{"date":"2020-07-24","current":37.537078,"twenty":30.71291,"median":36.149452,"eighty":43.037844,"marketCap":3365424257},{"date":"2020-07-31","current":40.350852,"twenty":30.745133,"median":36.199495,"eighty":43.037844,"marketCap":3617696027},{"date":"2020-08-07","current":41.351038,"twenty":30.776927,"median":36.250246,"eighty":43.037844,"marketCap":3707368648},{"date":"2020-08-14","current":40.224323,"twenty":30.922362,"median":36.348523,"eighty":43.037844,"marketCap":3606351900},{"date":"2020-08-21","current":40.308676,"twenty":31.08368,"median":36.544296,"eighty":43.037844,"marketCap":3613914651},{"date":"2020-08-28","current":40.628012,"twenty":31.203975,"median":36.640352,"eighty":43.037844,"marketCap":3642545066},{"date":"2020-09-04","current":40.013441,"twenty":31.296906,"median":36.781594,"eighty":43.037844,"marketCap":3587445022},{"date":"2020-09-11","current":40.079718,"twenty":31.383772,"median":36.974643,"eighty":43.037844,"marketCap":3593387184},{"date":"2020-09-18","current":38.59149,"twenty":31.509762,"median":37.052903,"eighty":43.037844,"marketCap":3459958646},{"date":"2020-09-25","current":37.645532,"twenty":31.534039,"median":37.273263,"eighty":43.037844,"marketCap":3375147794},{"date":"2020-10-02","current":39.29644,"twenty":31.704694,"median":37.362034,"eighty":43.037844,"marketCap":3523161638},{"date":"2020-10-09","current":40.368928,"twenty":31.803276,"median":37.497873,"eighty":43.037844,"marketCap":3619316617},{"date":"2020-10-16","current":39.386818,"twenty":31.867808,"median":37.57347,"eighty":43.037844,"marketCap":3531264585},{"date":"2020-10-23","current":40.224079,"twenty":31.975443,"median":37.612137,"eighty":43.037844,"marketCap":3633239960},{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-22","current":43.002313,"twenty":37.571542,"median":40.653059,"eighty":44.677947,"marketCap":8227804641}],"updateTime":1748005517899}}}